Prediction of key genes in ovarian cancer treated with decitabine based on network strategy

  • Authors:
    • Yu-Zhen Wang
    • Sheng-Chun Qiu
  • View Affiliations

  • Published online on: March 23, 2016     https://doi.org/10.3892/or.2016.4697
  • Pages: 3548-3558
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The objective of the present study was to predict key genes in ovarian cancer before and after treatment with decitabine utilizing a network approach and to reveal the molecular mechanism. Pathogenic networks of ovarian cancer before and after treatment were identified based on known pathogenic genes (seed genes) and differentially expressed genes (DEGs) detected by Significance Analysis of Microarrays (SAM) method. A weight was assigned to each gene in the pathogenic network and then candidate genes were evaluated. Topological properties (degree, betweenness, closeness and stress) of candidate genes were analyzed to investigate more confident pathogenic genes. Pathway enrichment analysis for candidate and seed genes were conducted. Validation of candidate gene expression in ovarian cancer was performed by reverse transcriptase-polymerase chain reaction (RT-PCR) assays. There were 73 nodes and 147 interactions in the pathogenic network before treatment, while 47 nodes and 66 interactions after treatment. A total of 32 candidate genes were identified in the before treatment group of ovarian cancer, of which 16 were rightly candidate genes after treatment and the others were silenced. We obtained 5 key genes (PIK3R2, CCNB1, IL2, IL1B and CDC6) for decitabine treatment that were validated by RT-PCR. In conclusion, we successfully identified 5 key genes (PIK3R2, CCNB1, IL2, IL1B and CDC6) and validated them, which provides insight into the molecular mechanisms of decitabine treatment and may be potential pathogenic biomarkers for the therapy of ovarian cancer.
View Figures
View References

Related Articles

Journal Cover

June-2016
Volume 35 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang Y and Wang Y: Prediction of key genes in ovarian cancer treated with decitabine based on network strategy. Oncol Rep 35: 3548-3558, 2016
APA
Wang, Y., & Wang, Y. (2016). Prediction of key genes in ovarian cancer treated with decitabine based on network strategy. Oncology Reports, 35, 3548-3558. https://doi.org/10.3892/or.2016.4697
MLA
Wang, Y., Qiu, S."Prediction of key genes in ovarian cancer treated with decitabine based on network strategy". Oncology Reports 35.6 (2016): 3548-3558.
Chicago
Wang, Y., Qiu, S."Prediction of key genes in ovarian cancer treated with decitabine based on network strategy". Oncology Reports 35, no. 6 (2016): 3548-3558. https://doi.org/10.3892/or.2016.4697